Showing items 1 - 4 of 4

Your selections:

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

- Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua

Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1

- Zhan, ZhenZhen, Li, Qun, Wu, Ping, Ye, Yan, Tseng, Hsin-Yi, Zhang, Linjie, Zhang, Xu Dong

Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells

- Zhu, Bi-ke, Wang, Ping, Zhang, Xu Dong, Jiang, Chen Chen, Chen, Li Hua, Avery-Kiejda, Kelly A., Watts, Ralph, Hersey, Peter

Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia: an in vivo study

- Verrills, Nicole M., Liem, Natalia L., Liaw, Tracey Y. E., Hood, Brian D., Lock, Richard B., Kavallaris, Maria

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit